Get the latest crypto news, updates, and reports by subscribing to our free newsletter.
Giấy phép số 4978/GP-TTĐT do Sở Thông tin và Truyền thông Hà Nội cấp ngày 14 tháng 10 năm 2019 / Giấy phép SĐ, BS GP ICP số 2107/GP-TTĐT do Sở TTTT Hà Nội cấp ngày 13/7/2022.
© 2026 Index.vn
At Build to Last 2026, Saint-Gobain Vietnam announced it has achieved “Zero Carbon” manufacturing for its DURAflex fiber cement sheet plant in Quảng Trị, with no carbon emissions for Scope 1 and Scope 2. The company said it is the first in its industry to reach this milestone. The Zero…
Wolf Haldenstein Adler Freeman & Herz LLP announced that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) in the United States District Court for the Southern District of Ohio. The lawsuit is brought on behalf of all persons and entities who purchased or otherwise acquired Medpace common stock between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”). Investors have until June 5, 2026 to apply to the Court to be appointed as lead plaintiff.
According to the filed complaint, the defendants made “overwhelmingly positive” statements to investors while allegedly disseminating false and misleading statements and/or concealing material adverse facts related to Medpace’s backlog cancellation rate. The complaint states that defendants repeatedly touted well-behaved cancellation rates.
The complaint further alleges that Medpace indicated cancellations were not driven by weak business conditions or a weak funding environment, while providing investors with overly positive growth expectations that could not be maintained alongside a projected 1.15 book-to-bill ratio.
On February 9, 2026, Medpace issued a press release stating its fourth quarter 2025 book-to-bill ratio was 1.04, which the announcement described as well below guidance of 1.15.
Following the news, Medpace’s common stock declined sharply. The stock fell from a closing price of $530.35 per share on February 9, 2026 to $446.05 per share on February 10, 2026, representing a decline of more than 15.9%.
The firm stated that there is no cost or obligation to speak with an attorney.
Investors seeking lead plaintiff appointment must apply by June 5, 2026.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
